Top Story

OSN Europe: Advances in IOL technology lead to better results, patient-customized options

August 4, 2015

A new generation of premium lenses promises to offer opportunities for increasingly accurate refraction, customized to the individual patient.

“It is a changing scenario in which cataract and refractive lens exchange (RLE) patients can expect considerably better results, major advantages and fewer problems. It is going to be an exciting time, with a lot of innovation in technologies, a brighter future for the patients and expansion for the market,” Jorge L. Alió, MD, PhD, OSN Europe Edition Board Member, said.

Darrell White Blog

BLOG: Measuring dry eye symptoms — SANDE doesn’t measure up

August 4, 2015
The most important measurement in treating dry eye is patient symptoms. Remember? You have to know what’s bugging them so you know what to fix. It’s helpful…
FDA News

Bausch + Lomb receives 510(k) clearance for modified Victus interface kit

August 3, 2015
Bausch + Lomb has received 510(k) clearance from the FDA for an enhanced patient interface kit for the Victus femtosecond laser platform, according to a company…
Breaking News

Omeros receives marketing authorization for Omidria in European Union

August 3, 2015
The European Commission has granted marketing authorization for Omidria for use in cataract surgery and lens replacement procedures in the European Union, Omeros…
Shire acquires Foresight Biotherapeutics for $300 million Business News

Shire acquires Foresight Biotherapeutics for $300 million

August 3, 2015
Shire has acquired privately held Foresight Biotherapeutics for a cash payment of $300 million, according to a press release.The acquisition includes the global rights…
More News Headlines »
Practical Retina

Comparing Aflibercept, Bevacizumab, and Ranibizumab for DME: Analysis of DRCR Protocol T

Ophthalmic Surgery, Lasers and Imaging Retina, March 2015, Volume 46 Issue 3
More »
Real-world Use of Anti-VEGF Therapy

Real-world Use of Anti-VEGF Therapy

This activity is supported by an educational grant from Genentech, Inc.

Anti-VEGF is well established as first-line therapy for the treatment of diabetic macular edema (DME) and age-related…
More »
Meeting News Coverage Video
VIDEO: Defining and treating astigmatism

VIDEO: Defining and treating astigmatism

July 26, 2015
At the Kiawah Eye 2015 meeting, John A. Hovanesian, MD, FACS, discusses how treating astigmatism in patients will…
More »